Wakix 17.8 MG Oral Tablet

RxCUI: 2197894
RxNorm name: Wakix 17.8 MG Oral Tablet
Display name: Wakix 17.8 MG Oral Tablet
Full name: Wakix 17.8 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Wakix	PITOLISANT HYDROCHLORIDE	Harmony Biosciences, LLC	8daa5562-824e-476c-9652-26ceef3d4b0e	2026-02-13	Warnings, Adverse reactions	Exact identifier rxcui: 2197894

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
8daa5562-824e-476c-9652-26ceef3d4b0e	Wakix 17.8 MG Oral Tablet [PSN] · pitolisant 17.8 MG Oral Tablet [Wakix] [SBD] · Wakix 17.8 MG (as pitolisant HCl 20 MG) Oral Tablet [SY] · Wakix 17.8 MG Oral Tablet [SY]	4	18	These highlights do not include all the information needed to use WAKIX ® safely and effectively. See full prescribing information for WAKIX. WAKIX ® (pitolisant) tablets, for oral use Initial U.S. Approval: 2019	20260213